Schmekel B, Karlsson S E, Linden M, Sundström C, Tegner H, Venge P
Department of Explorative Clinical Research, AB Draco, Lund, Sweden.
Inflammation. 1990 Aug;14(4):447-54. doi: 10.1007/BF00914095.
The origin of myeloperoxidase (MPO) in bronchoalveolar lavage (BAL) was investigated in the first part of the study. Radioimmunoassay of the cellular and supernatant MPO content as well as the peroxidase-antiperoxidase (PAP) technique were employed to determine the cellular source of MPO. The concentrations of MPO were measured in serum and BAL in the second part of the study. The aim was to determine whether the capillary bed was also a source of MPO. Neutrophil numbers in BALs obtained from 20 healthy subjects correlated significantly to the concentrations of MPO in cell-free BAL supernatants (r = 0.643, P less than or equal to 0.01). The cellular content of MPO in mixed BAL cells was significantly correlated to the number of neutrophils in the mixture (r = 0.536, P less than 0.05), but not to the number of any other cells. Moreover, the PAP-technique identified MPO in lung tissue neutrophils in resection specimens obtained from three patients undergoing surgery. This technique also revealed strong MPO activity in all BAL neutrophils and a weak activity in merely 4% of the alveolar macrophages in cytospin preparations obtained from seven BALs. High BAL/serum ratio of MPO concentrations suggests that MPO is of local origin, rather than passively diffused from the circulating pool. We therefore conclude that strong evidence suggests that MPO in BAL originates from lung neutrophils and that BAL MPO content may be used to estimate the neutrophil presence or activation in epithelium lining fluid.
本研究的第一部分对支气管肺泡灌洗(BAL)中髓过氧化物酶(MPO)的来源进行了调查。采用放射免疫分析法测定细胞和上清液中的MPO含量,以及过氧化物酶-抗过氧化物酶(PAP)技术来确定MPO的细胞来源。在研究的第二部分中,测量了血清和BAL中的MPO浓度。目的是确定毛细血管床是否也是MPO的一个来源。从20名健康受试者获得的BAL中的中性粒细胞数量与无细胞BAL上清液中的MPO浓度显著相关(r = 0.643,P≤0.01)。混合BAL细胞中MPO的细胞含量与混合物中的中性粒细胞数量显著相关(r = 0.536,P<0.05),但与其他任何细胞的数量均无相关性。此外,PAP技术在3例接受手术患者的切除标本中的肺组织中性粒细胞中鉴定出了MPO。该技术还显示,在所有BAL中性粒细胞中MPO活性很强,而在从7份BAL获得的细胞涂片制剂中,仅4%的肺泡巨噬细胞中有微弱活性。MPO浓度的BAL/血清高比值表明MPO是局部来源,而非从循环池中被动扩散而来。因此,我们得出结论,有力证据表明BAL中的MPO源自肺中性粒细胞,且BAL中MPO含量可用于估计上皮衬液中中性粒细胞的存在或活化情况。